BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17070009)

  • 1. Voice therapy improves quality of life in age-related dysphonia: a case-control study.
    Berg EE; Hapner E; Klein A; Johns MM
    J Voice; 2008 Jan; 22(1):70-4. PubMed ID: 17070009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results.
    Paniello RC; Barlow J; Serna JS
    Laryngoscope; 2008 Mar; 118(3):564-8. PubMed ID: 18216744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II.
    Rubin AD; Wodchis WP; Spak C; Kileny PR; Hogikyan ND
    Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):415-20. PubMed ID: 15096423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurovegetative symptoms and complaints before and after voice therapy for nonorganic habitual dysphonia.
    Demmink-Geertman L; Dejonckere PH
    J Voice; 2008 May; 22(3):315-25. PubMed ID: 17241768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain.
    Thomas L; Jones TM; Tandon S; Carding P; Lowe D; Rogers S
    Clin Otolaryngol; 2009 Feb; 34(1):34-42. PubMed ID: 19260883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of voice and swallowing problems in the elderly.
    Turley R; Cohen S
    Otolaryngol Head Neck Surg; 2009 Jan; 140(1):33-6. PubMed ID: 19130958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vocal outcome measures after bilateral posterior cricoarytenoid muscle botulinum toxin injections for abductor spasmodic dysphonia.
    Klein AM; Stong BC; Wise J; DelGaudio JM; Hapner ER; Johns MM
    Otolaryngol Head Neck Surg; 2008 Sep; 139(3):421-3. PubMed ID: 18722224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of Parkinson's-related dysphonia.
    Sewall GK; Jiang J; Ford CN
    Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reported voice-related quality of life in adolescents with paradoxical vocal fold dysfunction.
    Mirasola KL; Braun N; Blumin JH; Kerschner JE; Merati AL
    J Voice; 2008 May; 22(3):373-8. PubMed ID: 17241769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voice-related quality of life after treatment of laryngeal cancer.
    Oridate N; Homma A; Suzuki S; Nakamaru Y; Suzuki F; Hatakeyama H; Taki S; Sakashita T; Nishizawa N; Furuta Y; Fukuda S
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):363-8. PubMed ID: 19380358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes and complications between awake and asleep injection laryngoplasty: a case-control study.
    Mathison CC; Villari CR; Klein AM; Johns MM
    Laryngoscope; 2009 Jul; 119(7):1417-23. PubMed ID: 19507236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of voice therapy for teachers with dysphonia.
    Niebudek-Bogusz E; Sznurowska-Przygocka B; Fiszer M; KotyƂo P; Sinkiewicz A; Modrzewska M; Sliwinska-Kowalska M
    Folia Phoniatr Logop; 2008; 60(3):134-41. PubMed ID: 18334848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of the Voice Handicap Index (VHI) and the Voice-Related Quality of Life Measure (V-RQOL).
    Portone CR; Hapner ER; McGregor L; Otto K; Johns MM
    J Voice; 2007 Nov; 21(6):723-7. PubMed ID: 16887328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of voice therapy in patients after treatment for early glottic carcinoma.
    van Gogh CD; Verdonck-de Leeuw IM; Boon-Kamma BA; Rinkel RN; de Bruin MD; Langendijk JA; Kuik DJ; Mahieu HF
    Cancer; 2006 Jan; 106(1):95-105. PubMed ID: 16323175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between ratings of voice quality and quality of life measures.
    Murry T; Medrado R; Hogikyan ND; Aviv JE
    J Voice; 2004 Jun; 18(2):183-92. PubMed ID: 15193651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptual analyses of spasmodic dysphonia before and after treatment.
    Cannito MP; Woodson GE; Murry T; Bender B
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1393-9. PubMed ID: 15611398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of perceived dysphonia in a geriatric population.
    Golub JS; Chen PH; Otto KJ; Hapner E; Johns MM
    J Am Geriatr Soc; 2006 Nov; 54(11):1736-9. PubMed ID: 17087701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current dysphonia trends in patients over the age of 65: is vocal atrophy becoming more prevalent?
    Davids T; Klein AM; Johns MM
    Laryngoscope; 2012 Feb; 122(2):332-5. PubMed ID: 22252988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of voice therapy assessed with the Voice Range Profile (Phonetogram).
    DeJonckere PH; van Wijck I; Speyer R
    Rev Laryngol Otol Rhinol (Bord); 2003; 124(5):285-9. PubMed ID: 15144023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voice therapy in pediatric functional dysphonia: a prospective study.
    Trani M; Ghidini A; Bergamini G; Presutti L
    Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):379-84. PubMed ID: 17137639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.